SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (1582)1/25/1999 12:16:00 PM
From: David Bogdanoff  Read Replies (1) | Respond to of 2173
 
To all;

The company has reported some preliminary diabetes trial results which
seem consistent with previous results.

David



To: arnie h who wrote (1582)1/31/1999 8:46:00 AM
From: LLCF  Read Replies (1) | Respond to of 2173
 
<Looks like AMLN has staved off delisting since the price closed at $1 or above for 10 consecutive days. The clock doesn't start tickling again until the price is below $1 for 30 consecutive days. >

Ooops.... "spoof":

<http://biz.yahoo.com/prnews/990129/ca_amylin__1.html>

Looks like this thing is "toast".

DAK


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News